<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in fibroblast growth factor receptor 2 (FGFR2), a transmembrane receptor expressed in suture mesenchyme, osteogenic fronts, and dura, have been implicated in the etiopathogenesis of <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>The C278F- and P253R-FGFR2 mutations result in <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndromes</z:e>, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>The dura mater plays a critical role in the formation and maintenance of cranial sutures </plain></SENT>
<SENT sid="3" pm="."><plain>However, its role in syndromic <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> remains unclear </plain></SENT>
<SENT sid="4" pm="."><plain>This study examines the influence of FGFR2 mutations in dural cells on osteoblast proliferation and differentiation </plain></SENT>
<SENT sid="5" pm="."><plain>Primary cultures of dural cells and osteoblasts were established, and adenoviral-FGFR2 constructs were prepared by subcloning mutant (C278F and P253R) FGFR2 constructs into adenovirus </plain></SENT>
<SENT sid="6" pm="."><plain>Dural cells were infected with adenovirus, and dural protein expression was confirmed by immunostaining </plain></SENT>
<SENT sid="7" pm="."><plain>Infected dural cells were cocultured with osteoblasts using a transwell system for 7 days </plain></SENT>
<SENT sid="8" pm="."><plain>Dural cells infected with null adenovirus served as the negative control </plain></SENT>
<SENT sid="9" pm="."><plain>In separate cultures, osteoblasts were directly infected with the adenoviral-FGFR2 constructs </plain></SENT>
<SENT sid="10" pm="."><plain>Osteoblast proliferation was analyzed by <z:chebi fb="0" ids="53233">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</z:chebi> (<z:chebi fb="0" ids="53233">MTT</z:chebi>) assay, and differentiation was analyzed by alkaline phosphatase assay, histochemical staining, and gene expression studies </plain></SENT>
<SENT sid="11" pm="."><plain>Osteoblasts directly infected with the <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> (C278F-FGFR2) mutation demonstrated an increase in cell proliferation (P &lt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>Osteoblasts directly infected with the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> (P253R-FGFR2) mutation demonstrated an increase in alkaline phosphatase activity </plain></SENT>
<SENT sid="13" pm="."><plain>In coculture experiments, osteoblasts cocultured with <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e>-transformed dural cells demonstrated <z:mp ids='MP_0000351'>increased cell proliferation</z:mp> (P &lt; 0.05), whereas osteoblasts cocultured with <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e>-transformed dural cells showed an increase in alkaline phosphatase activity (P &lt; 0.05) </plain></SENT>
<SENT sid="14" pm="."><plain>In addition, osteogenic gene expression (alkaline phosphatase, osteopontin, and runx2) were up-regulated in osteoblasts cocultured with <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e>-expressing dural cells </plain></SENT>
<SENT sid="15" pm="."><plain>These experiments suggest that FGFR2 mutations in dural cells alter <z:mpath ids='MPATH_458'>normal</z:mpath> dural signaling </plain></SENT>
<SENT sid="16" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> mutations promote osteodifferentiation, whereas <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> mutations result in enhanced cell proliferation </plain></SENT>
<SENT sid="17" pm="."><plain>These mutations may induce <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> in part through the influence of mutation-induced constitutive signaling in the dura, with subsequent enhancement of dural-mediated osteogenesis </plain></SENT>
</text></document>